FRIDAY, Sept. 10, 2021 (HealthDay News)
The U.S. Food and Drug Administration on Thursday announced that it had rejected the applications of nearly a million electronic cigarettes and related products.
But it also delayed a decision on the fate of the leading vape product brand, Juul, drawing an outcry from anti-vaping groups.
Juul products will remain on the market for now, more than 10 years after e-cigarettes first began selling in the United States, while the FDA defers its decision to an unspecified later time.
“There’s more work to be done to complete our remaining reviews and ensure that we continue taking appropriate action to protect our nation’s youth from the dangers of all tobacco products, including e-cigarettes,” the FDA said in a statement, according to an Associated Press report.
The decision was part of a large scientific review of the vaping industry amid a court-ordered deadline to issue decisions